StarDrop’s glowing molecule provides visual link between chemical structure and predicted toxicities
25 May 2011 | By The Scott Partnership
Optibrium, announce a range of models to help predict the toxicity of new compounds...
List view / Grid view
News
Thermo Fisher Scientific helps optimise productivity of bioequivalence studies and regulatory compliance
Thermo Fisher Scientific Inc., the world leader in serving science, today announced that International Pharmaceutical Research Center (IPRC) has implemented Thermo Scientific Watson LIMS (laboratory information management system) to improve productivity of its Phase I clinical trials unit while enabling compliance with current regulatory requirements.
Tecan’s new Infinite® M1000 – the future of microplate detection has just arrived
24 May 2011 | By kdm communications limited
Tecan has recently updated its Infinite M1000 high-end multimode microplate reader with new features...
AstraZeneca signs agreement in Japan with Daiichi Sankyo
24 May 2011 | By AstraZeneca
AstraZeneca signs agreement with Daiichi Sankyo for denosumab for the treatment of bone disorders...
Abbott completes submission of new molecular test
23 May 2011 | By Abbott
Abbott announced it filed premarket approval applications for a new molecular diagnostic test...
Aesica to increase presence in Asia
23 May 2011 | By Velvet Communications
Aesica Pharmaceuticals has announced the promotion of Joe Zou to manage regional sales across Asia...
Lab21 acquires molecular diagnostics company Myconostica Ltd
23 May 2011 | By College Hill
Lab21 Limited, has announced that it has acquired Myconostica Ltd...
Preventing prostate cancer cells from ‘bodybuilding’ gives new treatment hope
20 May 2011 | By Cancer Research UK
Cancer Research scientists discover that stopping prostate cancer cells ‘bulking up’ with nutrients reduces spread of the disease...
ELIQUIS® (apixaban) approved in Europe for preventing venous thromboembolism
20 May 2011 | By Bristol-Myers Squibb Company
The European Commission has approved ELIQUIS® in the 27 countries of the EU...
GSK and Human Genome Sciences receive positive opinion in Europe from the CHMP for Benlysta® (belimumab)
20 May 2011 | By GlaxoSmithKline
The CHMP has issued a positive opinion, recommending marketing authorisation for Benlysta® (belimumab)...
Amgen receives CHMP positive opinion for XGEVA(TM) (Denosumab) in the European Union
20 May 2011 | By Amgen
Amgen announced that the CHMP of the EMA has recommended a positive opinion for the marketing authorization of XGEVA™ (denosumab)...
CHMP issues positive opinion for Merck’s VICTRELIS™ (boceprevir)
20 May 2011 | By Merck
Merck announced that the CHMP of the EMA has adopted a positive opinion under accelerated assessment recommending approval of the investigational medicine VICTRELIS™...
Cephalon granted Temporary Restraining Order in AMRIX® patent litigation
20 May 2011 | By Cephalon Inc
The United States District Court for the District of Delaware granted a motion filed by plaintiffs Cephalon and Eurand for a TRO enjoining Mylan Pharmaceuticals and Mylan from manufacturing, using and selling its cyclobenzaprine hydrochloride extended-release capsules...
European Medicines Agency’s Committee for Medicinal Products for Human Use issues positive opinion on marketing authorisation application for FAMPYRA
20 May 2011 | By Biogen Idec
Biogen Idec announced that FAMPYRA(R) (prolonged-release fampridine tablets) has been granted a positive opinion for conditional approval from the EMA's CHMP...
Abbott statement on the FDA Advisory Committee recommendations on fenofibric acid
19 May 2011 | By Abbott
Results of the ACCORD Lipid study...
